Corentec Co., Ltd. Stock

Equities

A104540

KR7104540000

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 18:00:00 2024-04-29 EDT 5-day change 1st Jan Change
9,220 KRW +0.22% Intraday chart for Corentec Co., Ltd. -0.32% -22.13%

Financials

Sales 2022 63.91B 46.14M 63.59M Sales 2023 92.05B 66.46M 91.59M Capitalization 151B 109M 150M
Net income 2022 1.78B 1.29M 1.77M Net income 2023 4.06B 2.93M 4.03M EV / Sales 2022 2.19 x
Net Debt 2022 6.79B 4.9M 6.75M Net Debt 2023 20.43B 14.75M 20.33M EV / Sales 2023 1.86 x
P/E ratio 2022
74 x
P/E ratio 2023
47 x
Employees 196
Yield 2022 *
-
Yield 2023
-
Free-Float 79.57%
More Fundamentals * Assessed data
Dynamic Chart
Corentec Co., Ltd. announced that it has received KRW 1.19999236 billion in funding CI
Corentec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Corentec Co., Ltd. completed the acquisition of 80% stake in Woosung Pharmaceutical Co., Ltd. CI
Corentec Co., Ltd. agreed to acquire 80% stake in Woosung Pharmaceutical Co., Ltd. for KRW 7.2 billion. CI
Corentec Co., Ltd. announced that it expects to receive KRW 1.19999236 billion in funding CI
Corentec Appoints Michael Son as Executive Vice President CI
Corentec Co., Ltd. agreed to acquire an additional 26.01782% stake in Sun Healthcare International Corp. for KRW 7.8 billion. CI
Corentec Co., Ltd. announced that it has received KRW 20 billion in funding CI
Corentec Co., Ltd. announced that it expects to receive KRW 20 billion in funding CI
Corentec Co., Ltd.(KOSDAQ:A104540) added to S&P Global BMI Index CI
Corentec Co., Ltd. announced that it has received KRW 2.999888 billion in funding CI
Corentec Co., Ltd. announced that it expects to receive KRW 2.999888 billion in funding CI
Corentec Co., Ltd. announced that it has received KRW 19.39 billion in funding from Pureun Partners Asset Management, Sun Healthcare International Corp., Misan Corporation, and other investors CI
Corentec Co., Ltd. announced that it expects to receive KRW 19.39 billion in funding from Pureun Partners Asset Management, Sun Healthcare International Corp., Misan Corporation, and other investors CI
Corentec Co., Ltd. announced that it has received KRW 3.5000021 billion in funding from Union Pharmacy Co. Ltd., Seoul Pharmacy Do Ltd CI
More news
1 day+0.22%
1 week-0.32%
Current month-15.41%
1 month-15.41%
3 months-20.03%
6 months-12.36%
Current year-22.13%
More quotes
1 week
9 130.00
Extreme 9130
9 600.00
1 month
9 100.00
Extreme 9100
11 080.00
Current year
9 100.00
Extreme 9100
12 920.00
1 year
9 100.00
Extreme 9100
14 740.00
3 years
8 550.00
Extreme 8550
18 900.00
5 years
5 820.00
Extreme 5820
22 850.00
10 years
4 890.00
Extreme 4890
22 850.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 -
Chief Executive Officer 61 20-03-26
Chief Executive Officer 66 01-12-31
Members of the board TitleAgeSince
Chief Executive Officer 66 01-12-31
Chief Executive Officer 61 20-03-26
Chief Executive Officer 65 -
More insiders
Date Price Change Volume
24-04-29 9,220 +0.22% 24 645
24-04-29 9,200 -1.60% 68,970
24-04-26 9,350 +0.65% 20,514
24-04-25 9,290 -0.75% 21,708
24-04-24 9,360 -0.85% 45,082

End-of-day quote Korea S.E., April 29, 2024

More quotes
Corentec Co., Ltd. is a Korea-based company engaged in the development, manufacture and sale of orthopedic implants. The Company’s products consist of hip products, including primary systems, hemi-arthroplasty systems and revision systems, such as cementless femoral stems, cemented femoral stems, cups for acetabular systems, bearing systems and others; knee products, including primary knee system fixed type, primary knee system mobile type, revision knee systems and augments systems, and spine products, including pedicle screws and peek cages. The Company mainly provides its hip products under the brand name of BENCOX, knee products under the brand name of LOSPA and spine products under the brand name of LOSPA IS. The Company distributes its products within domestic market and to overseas markets.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A104540 Stock